Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...
"We are thrilled to have our first participant enrolled," said Chief Executive Officer Cheri Ackerman. "For the millions of people who suffer from atopic dermatitis (AD), or eczema, ENS-002 represents ...
The RAD Annual Meeting is known for its revolutionizing approach to dermatology education, including focused congresses in atopic dermatitis, alopecia areata, vitiligo, and eczema. It will be ...
ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitisZORYVE, a next-generation topical phosphodiesterase-4 ...
Therefore, the present collaboration holds the potential to improve prediction, prevention and the prognosis of children at risk for development of eczema and may have clinical relevance for allergic ...